Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 11:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Deep Partial Thickness Burn, Full Thickness Burns
Interventions: Mepitel One; Device
Lead sponsor: Molnlycke Health Care AB; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 4
States / cities: Tampa, Florida • Augusta, Georgia • Kansas City, Kansas + 1 more

Conditions: Early Alzheimer's Disease
Interventions: Experimental: ALZ-801; Drug
Lead sponsor: Alzheon Inc.; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 29
States / cities: Phoenix, Arizona • Sun City, Arizona • Costa Mesa, California + 26 more

Conditions: Squamous Cell Carcinoma of the Head and Neck
Interventions: Panitumumab, Carboplatin, Paclitaxel, Intensity Modulated Radiation Therapy, 5-Fluorouracil, Docetaxel, Cisplatin; Drug · Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Chronic Lymphocytic Leukemia
Interventions: lenalidomide, Rituximab, Fludarabine; Drug
Lead sponsor: SCRI Development Innovations, LLC; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 6
States / cities: Fort Myers, Florida • Orlando, Florida • Bethesda, Maryland + 2 more

Conditions: PreDiabetes, Diabetes Mellitus, Type 2, Healthy
Interventions: Post prandial testing; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Neovascular Age-related Macular Degeneration
Interventions: Not listed
Lead sponsor: Notal Vision Inc.; Industry
Eligibility: 55 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 7
States / cities: Marietta, Georgia • Lexington, Kentucky • Glen Burnie, Maryland + 4 more

Conditions: Work of Breathing
Interventions: Ambient Noise, Increased Auditory Feedback, Noise Distraction; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Postprandial Effect of Carbohydrate Beverage Consumption
Interventions: 15% protein, 30% protein, Sweetened beverage; Other
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Gastric Cancer
Interventions: Roux-en-Y pouch reconstruction (RYP), conventional Roux-en-Y reconstruction (RYC); Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Herpes Labialis
Interventions: NB-001 (0.3%), Placebo; Drug
Lead sponsor: NanoBio Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 362 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 12
States / cities: Chandler, Arizona • Tucson, Arizona • Chicago, Illinois + 9 more

Conditions: Concussion, Mild, Mild Traumatic Brain Injury (mTBI), Psychological Health
Interventions: Acceptance and Commitment Therapy Integrated Rehabilitation (ACT), Usual Care Rehabilitation; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 49 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Fort Hood, Texas

Conditions: Perinatal Depression
Interventions: Center M, Treatment as Usual; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Pain, Chronic, Prescription Drug Abuse (Not Dependent)
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Shared Decision Making
Interventions: Intervention-specific Carevive questionnaire, Standard of Care questionnaire; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Female only
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Allergic Conjunctivitis
Interventions: Olopatadine hydrochloride, 0.1% ophthalmic solution (Patanol), Dextran 70 0.1%, hydroxypropyl methylcellulose 0.3% (Tears Naturale II); Drug · Other
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Breast Cancer
Interventions: Breast Cancer Screening, Survey/Interview, Focus Group; Diagnostic Test · Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 30 Years to 75 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Esophageal Cancer
Interventions: paclitaxel; Drug
Lead sponsor: Theradex; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 30
States / cities: Mobile, Alabama • Loma Linda, California • San Francisco, California + 25 more

Conditions: Systemic Lupus Erythematosus
Interventions: TEACH; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 12 Years to 22 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Mental Disorders
Interventions: Mental Health eConsults, Care as usual; Other
Lead sponsor: University of Minnesota; Other
Eligibility: Not listed
Enrollment: 900,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Surgery
Interventions: 2% CHG Cloth solution, Vehicle Cloth, Active Comparator, Saline, SLS; Drug · Device · Other
Lead sponsor: Medline Industries; Industry
Eligibility: 16 Years and older
Enrollment: 249 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Butte, Montana

Conditions: Angiography
Interventions: Endovascular Diagnostic Procedures; Device
Lead sponsor: Cardiovascular Associates of the Delaware Valley; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Healthy
Interventions: Metformin, Canagliflozin (JNJ-28431754); Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Neptune City, New Jersey

Conditions: Relationship Disorder
Interventions: Imago Relationship Therapy, Waitlist with Bibliotherapy followed by Workshop; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Traumatic Brain Injury, Chronic Traumatic Encephalopathy, Mild Cognitive Impairment
Interventions: Amyvid PET Scan, T807 PET scan; Drug
Lead sponsor: Samuel Gandy; Other
Eligibility: 40 Years to 85 Years · Male only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

Post Prandial Individual Responses to Different Foods

Home OCT Fluid Visualization Agreement Study

The Role of Breathing Perception in Respiratory Control

Fat Burning After a Meal

Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma

NB-001 Treatment of Recurrent Herpes Labialis

Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE) RCT

Center M: Digital Health Innovation Pilot

Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain

Enhancing Shared Decision-Making in Breast Cancer

Assessment of Alcon's Ocular Image Quantification System

Individuals on Hormone Therapy Breast Cancer Screening Pilot

Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus

Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus

Mental Health eConsults

Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth

Mynx M5 One Hour Ambulation Study

A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy Volunteers

A Randomized Controlled Trial of Imago Relationship Therapy

Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury